Capricor Therapeutics (CAPR) Total Current Liabilities (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Total Current Liabilities of $33.6 million for Q1 2026, up 50.59% year-over-year from $22.3 million in Q1 2025, and down 6.14% quarter-over-quarter from $35.8 million in Q4 2025.
Capricor Therapeutics (CAPR) Total Current Liabilities (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $33.6 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 50.59% year-over-year to $33.6 million; the TTM figure through Mar 2026 stood at $33.6 million (up 50.59% YoY), while the FY2025 annual figure was $35.8 million, up 70.44% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $33.6 million, down from $35.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $37.1 million in Q1 2023, with the low at $14.3 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $26.4 million (2024), against an average of $26.8 million.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 676.18% in 2022, then tumbled 37.81% in 2024.
- Capricor Therapeutics' Total Current Liabilities stood at $23.6 million in 2022, then soared by 32.57% to $31.3 million in 2023, then plunged by 32.76% to $21.0 million in 2024, then jumped by 70.44% to $35.8 million in 2025, then dropped by 6.14% to $33.6 million in 2026.
- Business Quant data shows CAPR's Total Current Liabilities at $33.6 million in Q1 2026, $35.8 million in Q4 2025, and $28.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 33.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.64 Mn |
| Dec 31, 2025 | 35.84 Mn |
| Sep 30, 2025 | 28.15 Mn |
| Jun 30, 2025 | 28.40 Mn |
| Mar 31, 2025 | 22.34 Mn |
| Dec 31, 2024 | 21.03 Mn |
| Sep 30, 2024 | 20.48 Mn |
| Jun 30, 2024 | 22.35 Mn |
| Mar 31, 2024 | 26.38 Mn |
| Dec 31, 2023 | 31.27 Mn |
| Sep 30, 2023 | 32.93 Mn |
| Jun 30, 2023 | 35.15 Mn |
| Mar 31, 2023 | 37.13 Mn |
| Dec 31, 2022 | 23.59 Mn |
| Sep 30, 2022 | 23.19 Mn |
| Jun 30, 2022 | 19.55 Mn |
| Mar 31, 2022 | 14.32 Mn |
| Dec 31, 2021 | 4.13 Mn |
| Sep 30, 2021 | 2.99 Mn |
| Jun 30, 2021 | 3.17 Mn |